Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_assertion type Assertion NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_head.
- NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_assertion description "[A growth inhibitory assay showed that only one FGF3/FGF4-amplified and three FGFR2-amplified cancer cell lines exhibited hypersensitivity to sorafenib in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_provenance.
- NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_assertion evidence source_evidence_literature NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_provenance.
- NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_assertion SIO_000772 22890726 NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_provenance.
- NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_assertion wasDerivedFrom befree-20150227 NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_provenance.
- NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_assertion wasGeneratedBy ECO_0000203 NP401398.RAXMAI7dXy4ARtNbJ6rCPY_1ENMqqlzMvE3EQB5ln6hK8130_provenance.